3 reports

  • OCT 11, 2016: VBI VACCINES COMPLETES PRE-IND MEETING FOR ITS GLIOBLASTOMA IMMUNOTHERAPY CANDIDATE
  • VBI-1901 - DRUG PROFILE

Cellular immunotherapy acts against pp##.

  • Hospital
  • Immunotherapy
  • Infectious Disease
  • Vaccine
  • VBI Vaccines Inc.
  • Oct 11, 2016: VBI Vaccines Completes Pre-IND Meeting for its Glioblastoma Immunotherapy Candidate
  • Aug 28, 2017: VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at the Immuno-Oncology Summit

Cellular immunotherapy acts against pp##.

  • Immunotherapy
  • Vaccine
  • United States
  • World
  • VBI Vaccines Inc.
  • VBI-1901 - DRUG PROFILE

THE MOLECULES DEVELOPED BY COMPANIES IN PHASE II, PHASE I, IND/ CTA FILED, PRECLINICAL AND DISCOVERY STAGES ARE ##, ##, ##, ## AND ## RESPECTIVELY.

  • Immunotherapy
  • Infectious Disease
  • Protein Therapy
  • Vaccine
  • VBI Vaccines Inc.